Default: Journal of Thrombosis and Haemostasis

ISSN: 1538-7933

Journal Home

Journal Guideline

Journal of Thrombosis and Haemostasis Q1 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Thrombosis and Haemostasis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 178. It has a price of 2600 €. It has an SJR impact factor of 1,947 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,947.

Journal of Thrombosis and Haemostasis focuses its scope in these topics and keywords: pulmonary, venous, management, review, embolism, patients, systematic, clinical, computed, activity, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2600 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Journal of Thrombosis and Haemostasis

1,947

SJR Impact factor

178

H Index

448

Total Docs (Last Year)

905

Total Docs (3 years)

14428

Total Refs

3573

Total Cites (3 years)

711

Citable Docs (3 years)

3,96

Cites/Doc (2 years)

32,21

Ref/Doc

Aims and Scope


pulmonary, venous, management, review, embolism, patients, systematic, clinical, computed, activity, blood, major, cohort, factor, plasma, bleeding, risk, tomography, coagulation, hemophilic, hemostasis, rivaroxaban, thromboembolism,



Best articles by citations

Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation

View more

Prevalence of inherited bleeding disorders in cases of idiopathic menorrhagia: a case of five blind men describing an elephant

View more

Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor

View more

FORUM

View more

Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation

View more

An association analysis between genetic polymorphisms of matrix metalloproteinase-3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese

View more

A different view of 'Toc', as I knew him

View more

Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection-related antiphospholipid antibodies

View more

Temporary inferior vena caval filter use in pregnancy

View more

Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism

View more

Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? No

View more

Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes

View more
SHOW MORE ARTICLES

The plasma hemostatic proteome: thrombin generation in healthy individuals

View more

Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes

View more

Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound1

View more

Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase

View more

Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No

View more

The benefits of excess EPCR

View more

Revisited role of microparticles in arterial and venous thrombosis

View more

Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates

View more

An informed consent form for treatment with oral anticoagulants

View more

Lupus anticoagulants and anticardiolipin antibodies: personal reminiscences, a little history, and some random thoughts

View more

More on: intensive factor VIII exposure and inhibitor development in mild hemophilia A

View more

Platelet-derived sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2

View more

Comments

No comments ... Be the first to comment!

FAQS